Interlaboratory concordance of PD‐L1 immunohistochemistry for non‐small‐cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|72|3|449-459

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.72, Iss.3, 2018-02, pp. : 449-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 92, Iss. 5, 2017-02 ,pp. : 283-290

Karger

Access to resources Recommend Favorite

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 271-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Pathology of Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 72, Iss. 3, 2005-06 ,pp. : 313-330

Karger

Access to resources Recommend Favorite

Hycamtin in the Therapy of Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 3-13

Karger

Access to resources Recommend Favorite